Yuan Zhi
Stock Analyst at B. Riley Securities
(2.00)
# 3,007
Out of 4,918 analysts
27
Total ratings
46.15%
Success rate
-7.93%
Average return
Main Sectors:
Stocks Rated by Yuan Zhi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIR Mirion Technologies | Reiterates: Buy | $17 → $22 | $20.81 | +5.72% | 3 | Jul 23, 2025 | |
| TOI The Oncology Institute | Initiates: Buy | $6 | $4.03 | +48.88% | 1 | Jul 16, 2025 | |
| CATX Perspective Therapeutics | Maintains: Buy | $9 → $12 | $3.89 | +208.48% | 3 | Jun 23, 2025 | |
| RDNT RadNet | Initiates: Buy | $69 | $55.77 | +23.72% | 1 | Jun 13, 2025 | |
| HYPR Hyperfine | Maintains: Buy | $1.2 → $1 | $1.18 | -15.25% | 2 | May 15, 2025 | |
| RADX Radiopharm Theranostics | Initiates: Buy | $15 | $5.03 | +198.51% | 1 | Mar 12, 2025 | |
| TNGX Tango Therapeutics | Maintains: Buy | $16 → $8 | $6.59 | +21.40% | 2 | Nov 11, 2024 | |
| AGEN Agenus | Maintains: Buy | $42 → $18 | $5.40 | +233.33% | 2 | Aug 14, 2024 | |
| CYRX Cryoport | Upgrades: Buy | $19 → $15 | $7.15 | +109.79% | 4 | Jul 31, 2024 | |
| CTSO Cytosorbents | Reiterates: Buy | $3 | $0.91 | +229.27% | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $61 → $79 | $32.41 | +143.75% | 3 | Feb 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $16 | $1.66 | +863.86% | 4 | Dec 11, 2023 |
Mirion Technologies
Jul 23, 2025
Reiterates: Buy
Price Target: $17 → $22
Current: $20.81
Upside: +5.72%
The Oncology Institute
Jul 16, 2025
Initiates: Buy
Price Target: $6
Current: $4.03
Upside: +48.88%
Perspective Therapeutics
Jun 23, 2025
Maintains: Buy
Price Target: $9 → $12
Current: $3.89
Upside: +208.48%
RadNet
Jun 13, 2025
Initiates: Buy
Price Target: $69
Current: $55.77
Upside: +23.72%
Hyperfine
May 15, 2025
Maintains: Buy
Price Target: $1.2 → $1
Current: $1.18
Upside: -15.25%
Radiopharm Theranostics
Mar 12, 2025
Initiates: Buy
Price Target: $15
Current: $5.03
Upside: +198.51%
Tango Therapeutics
Nov 11, 2024
Maintains: Buy
Price Target: $16 → $8
Current: $6.59
Upside: +21.40%
Agenus
Aug 14, 2024
Maintains: Buy
Price Target: $42 → $18
Current: $5.40
Upside: +233.33%
Cryoport
Jul 31, 2024
Upgrades: Buy
Price Target: $19 → $15
Current: $7.15
Upside: +109.79%
Cytosorbents
May 15, 2024
Reiterates: Buy
Price Target: $3
Current: $0.91
Upside: +229.27%
Feb 1, 2024
Maintains: Buy
Price Target: $61 → $79
Current: $32.41
Upside: +143.75%
Dec 11, 2023
Maintains: Buy
Price Target: $20 → $16
Current: $1.66
Upside: +863.86%